Month: August 2025

Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume CleanCap® for commercialized vaccine programs, grew 5% year-over-year Net Loss Reduction, Positive Adjusted EBITDA and Positive Free Cash Flow expected by second half 2026 SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2025, together with other business updates. Quarterly Results and Recent Highlights:Quarterly revenue of $47.4 million, Net loss of $(69.8) million (including a goodwill impairment...

CHICAGO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Monroe Capital Corporation (NASDAQ: MRCC) today announced its financial results for the second quarter ended June 30, 2025. In a separate joint release issued on August 7, 2025, MRCC and Horizon Technology Finance Corporation (“HRZN”) announced that they have entered into a definitive merger agreement (the “Merger Agreement”), under which MRCC would merge with and into HRZN (the “Merger”), subject to the receipt of certain shareholder approvals and the satisfaction of certain closing conditions. Additionally, MRCC announced that it has entered into an asset purchase agreement to sell its investment assets at fair value to Monroe Capital Income Plus Corporation (“MCIP”) immediately prior to the closing of the Merger (the “Asset Sale”), subject...

Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 34% year-over-year and was 41% of total revenue; CTV revenue grew over 50% year-over-year; Supply Path Optimization represented 55%+ of total activity; and Repurchased 3.5 million shares in Q2 2025, representing 7% of fully diluted shares. NO-HEADQUARTERS/REDWOOD CITY, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today reported financial results for the second quarter ending June 30, 2025. “We delivered a strong second quarter, with revenue and adjusted EBITDA exceeding expectations. We added new publishers, streamers and ad buyers to the platform, continued to scale Activate and commerce media, and saw...

MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (NYSE: PNNT) announced today its financial results for the third quarter ended June 30, 2025. HIGHLIGHTS      Quarter ended June 30, 2025 (unaudited)($ in millions, except per share amounts)                            Assets and Liabilities:          Investment portfolio (1)       $ 1,171.6  Net assets       $ 480.6  Net asset value per share       $ 7.36  Quarterly change in net asset value per share         (1.6 )%           Credit Facility       $ 316.4  2026 Notes, net of unamortized deferred financing costs       $ 149.2  2026-2 Notes, net of unamortized deferred financing costs       $ 163.7  Regulatory debt to equity       1.31x  Weighted average yield on debt investments         11.5 %           Operating Results:          Net...

BOULDER, Colo., Aug. 11, 2025 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, reported financial results for the second quarter ended June 30, 2025. Highlights:Gross profit increased 16% and revenue increased 12%, compared to Q2 of the prior year, which represents the sixth consecutive quarter of double digit increases Continued positive operating and free cash flow generation Gaia’s subsidiary, Igniton, raised $6 million in July, increasing Igniton’s implied post-money valuation to $106 million“As planned, we continued to deliver on positive free cash flow and double-digit growth for the quarter,” said Jirka Rysavy, Gaia’s Chairman. “In July, our subsidiary, Igniton, raised $6 million of private common equity financing, including $2.0 million from Gaia, at an implied...

Second Quarter 2025 Revenue of $25.8 million; Net Income of $37.7 million OMAHA, Neb., Aug. 11, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (Unaudited)In USD millions, except percentages Q2 2025   Q2 2024   % ChangeRevenue $ 25.8     $ 22.3       16 %Technology, development and user support   14.7       10.8       36 %General and administrative   18.8       9.1       107 %(Gain) loss on digital assets, net   (52.5 )     17.2       (405 %)Net income (loss)   37.7       (9.6 )     493 %                       “As Bitcoin, stablecoins, and digital assets continue their global expansion, so does...

Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in JuneNASHVILLE, Tenn., Aug. 11, 2025 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its second quarter results: Fellow shareholders, We are closer than we have ever been to delivering a regulated kitted transplant monitoring assay to the market – and we are pleased to report a series of recent and timely accomplishments that we believe amount to material progress. These recent developments, which we highlight below, as well as ongoing strategic discussions, have strengthened our confidence...

RESTON, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the second quarter ended June 30, 2025, and provided an update on the Company’s continued progress. Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “The six months of 2025 marked a period of exceptional progress for Lightbridge as we advanced our nuclear fuel technology. We achieved several critical milestones that position us strongly for the future, including successful co-extrusion demonstration at Idaho National Laboratory in February, completing the final experiment design review in June for our upcoming irradiation testing in the Advanced Test Reactor, and, most recently, successful...

Reports Quarterly Record Net Revenue and Gross Profit LAS VEGAS, Aug. 11, 2025 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to Asian restaurants and other businesses across the United States, reported its unaudited financial results for the quarter ended June 30, 2025. Second Quarter 2025 Financial ResultsNet revenue increased 4.1% to $314.9 million compared to $302.3 million in the prior year period. Gross profit increased 5.1% to $55.1 million compared to $52.5 million in the prior year period. Gross profit margin increased 13 basis points to 17.5% compared to the prior year period. Net income increased 117.0% to $0.5 million compared to net income of $0.2 million in the prior year period. Adjusted EBITDA increased 31.1% to...

Type A meeting with U.S. FDA scheduled to discuss Deramiocel BLA and path toward potential approval Capricor seeks to resubmit its BLA based on its existing dataset, with HOPE-3 data (expected in Q4 2025) potentially serving as supportive and confirmatory evidence, pending regulatory guidance All 483 observations noted in the Pre-License Inspection have been resolved and accepted by the FDA FDA clears IND for StealthX™ exosome-based vaccine; NIAID has initiated the Phase 1 clinical trial Cash balance of approximately $123 million expected to support planned operations into the fourth quarter of 2026 Capricor will host a conference call and webcast today at 4:30 p.m. ETSAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based...